{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:06:13Z","timestamp":1750997173905,"version":"3.41.0"},"reference-count":19,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2023,3,24]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Acute low back pain (LBP) is a common complaint in the emergency department and achieving effective analgesia can be challenging.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>\nIn this multicentre randomised double-blind clinical trial conducted at three EDs in Iran from August to November 2020, we assessed the efficacy and adverse effects of two muscle relaxants in patients aged 18 years or older who suffered LBP in the last 6 weeks. Group 1 received intravenous methocarbamol and group 2 received intravenous diazepam followed by a weight-based dose of intravenous morphine in both groups. Exclusion criteria mainly included non-spine aetiologies, cord compression, acute gastrointestinal bleeding, renal\/hepatic insufficiency, pregnancy, breast feeding and unstable vital signs. Pain scores and adverse events were measured by a Numeric Rating Scale (NRS) at baseline and after 30 and 60\u2009min by one of the researchers who was not involved with patient visits and was blinded to the intervention. We used\n<jats:italic>t<\/jats:italic>\n-test to assess the mean difference of NRS at 30 and 60\u2009min.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Out of 101 enrolled patients, 50 participants received methocarbamol and 51 diazepam. The baseline mean pain scores and demographic characteristics were not different between the study groups. Pain scores were reduced by both agents after 60\u2009min, with slightly greater pain reductions in the diazepam group in comparison with methocarbamol (mean difference \u22126.1, 95% CI \u22126.5 to \u22125.7 vs mean difference \u22125.2, 95% CI \u20135.7 to \u22124.7, respectively, p&lt;0.001). ED length of stay of patients did not differ between the groups (methocarbamol 5.9 vs diazepam 4.8\u2009hours, p=0.365). Patients receiving diazepam were more likely to report drowsiness (2 (4.0%) vs 15 (29.4%), p=0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In patients with LBP, the pain was relieved in the methocarbamol and diazepam groups after 60\u2009min. Although diazepam was more effective, its use was associated with a slightly higher risk of drowsiness.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Trial registration number<\/jats:title>\n<jats:p>\nThe protocol of this clinical trial was prospectively registered in the irct.ir (IRCTID: IRCT20151113025025N4;\n<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/irct.ir\/trial\/50148)\">https:\/\/irct.ir\/trial\/50148<\/jats:ext-link>\n) .\n<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/emermed-2021-211485","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T17:25:59Z","timestamp":1681752359000},"page":"493-498","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Methocarbamol versus diazepam in acute low back pain in the emergency department: a randomised double-blind clinical trial"],"prefix":"10.1136","volume":"40","author":[{"given":"Meisam","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abdorazzaghnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Yazdchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-0987","authenticated-orcid":false,"given":"Maryam","family":"Bahreini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2025062323050812000_40.7.493.1","article-title":"Low back pain (acute)","volume":"2011","author":"McIntosh","year":"2011","journal-title":"BMJ Clin Evid"},{"key":"2025062323050812000_40.7.493.2","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1097\/01.brs.0000244618.06877.cd","article-title":"Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002","volume":"31","author":"Deyo","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"2025062323050812000_40.7.493.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-017-1511-7","article-title":"Prevalence of low back pain in emergency settings: a systematic review and meta-analysis","volume":"18","author":"Edwards","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"2025062323050812000_40.7.493.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1958.02990190014003"},{"key":"2025062323050812000_40.7.493.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000134786.50087.d8"},{"key":"2025062323050812000_40.7.493.6","first-page":"427","article-title":"Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain","volume":"39","author":"Witenko","year":"2014","journal-title":"P T"},{"key":"2025062323050812000_40.7.493.7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.annemergmed.2014.11.011","article-title":"Managing nontraumatic acute back pain","volume":"66","author":"Edlow","year":"2015","journal-title":"Ann Emerg Med"},{"key":"2025062323050812000_40.7.493.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-7-200710020-00008"},{"key":"2025062323050812000_40.7.493.9","unstructured":"Dydyk AM , Jain NK , Gupta M . Opioid use disorder. Treasure Island (FL): StatPearls Publishing, 2022. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/"},{"key":"2025062323050812000_40.7.493.10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jemermed.2014.07.039","article-title":"A comparison of three self-report pain scales in adults with acute pain","volume":"48","author":"Bahreini","year":"2015","journal-title":"J Emerg Med"},{"key":"2025062323050812000_40.7.493.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0321-2"},{"key":"2025062323050812000_40.7.493.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-7-200710020-00006"},{"key":"2025062323050812000_40.7.493.13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ajem.2019.158489","article-title":"How much change in pain score does really matter to patients?","volume":"38","author":"Bahreini","year":"2020","journal-title":"Am J Emerg Med"},{"key":"2025062323050812000_40.7.493.14","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209588"},{"key":"2025062323050812000_40.7.493.15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s15006-015-3307-x","article-title":"Methocarbamol in acute low back pain. A randomized double-blind controlled study","volume":"157 Suppl 5","author":"Emrich","year":"2015","journal-title":"MMW Fortschr Med"},{"key":"2025062323050812000_40.7.493.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken470"},{"key":"2025062323050812000_40.7.493.17","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1097\/01.brs.0000137056.64166.51","article-title":"Quality of primary care guidelines for acute low back pain","volume":"29","author":"van Tulder","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"key":"2025062323050812000_40.7.493.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e497","article-title":"Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis","volume":"344","author":"Pinto","year":"2012","journal-title":"BMJ"},{"key":"2025062323050812000_40.7.493.19","first-page":"23","article-title":"Effects of two different doses of eperisone in the treatment of acute low back pain","volume":"9","author":"Rusinyol","year":"2009","journal-title":"J Appl Res"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2021-211485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:49:14Z","timestamp":1750938554000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2021-211485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,22]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/emermed-2021-211485"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2021-211485","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"type":"print","value":"1472-0205"},{"type":"electronic","value":"1472-0213"}],"subject":[],"published":{"date-parts":[[2023,4,17]]}}}